• BioRegenx filed a Form 12b-25 late filing notice for its Form 10-Q for quarter ended March 31, 2026.
• Quarterly report was not filed on time due to unanticipated delays that prevented completion of audit work and preparation of financial statements.
• Form 10-Q is expected to be filed within five calendar days after original due date.
• Notice indicated no anticipated significant change in results of operations versus corresponding prior-year period.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bioregenx Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001683168-26-003995), on May 15, 2026, and is solely responsible for the information contained therein.